Amy A. Irving

506 total citations
18 papers, 415 citations indexed

About

Amy A. Irving is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Amy A. Irving has authored 18 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Amy A. Irving's work include Vitamin D Research Studies (4 papers), Genetic factors in colorectal cancer (4 papers) and Digestive system and related health (3 papers). Amy A. Irving is often cited by papers focused on Vitamin D Research Studies (4 papers), Genetic factors in colorectal cancer (4 papers) and Digestive system and related health (3 papers). Amy A. Irving collaborates with scholars based in United States, India and Switzerland. Amy A. Irving's co-authors include John E. Moulder, Eric P. Cohen, William F. Dove, Linda Clipson, John P. Klein, Brian L. Fish, Lori A. Plum, Hector F. DeLuca, James Amos‐Landgraf and Mark Juckett and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Journal of Nutrition.

In The Last Decade

Amy A. Irving

18 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy A. Irving United States 13 138 128 104 84 72 18 415
Nicholas Armitage United Kingdom 7 93 0.7× 97 0.8× 103 1.0× 201 2.4× 85 1.2× 12 530
Yuko Ishikawa Japan 14 92 0.7× 50 0.4× 101 1.0× 149 1.8× 65 0.9× 44 503
Matthew R. Smith United Kingdom 6 129 0.9× 69 0.5× 30 0.3× 117 1.4× 177 2.5× 10 404
Shengnan Zhao China 12 136 1.0× 103 0.8× 39 0.4× 111 1.3× 178 2.5× 54 490
Tso‐Fu Wang Taiwan 13 135 1.0× 31 0.2× 51 0.5× 89 1.1× 67 0.9× 47 430
Lüder Fels Germany 10 138 1.0× 154 1.2× 82 0.8× 73 0.9× 94 1.3× 19 510
Leo Y. Luo United States 10 130 0.9× 31 0.2× 43 0.4× 91 1.1× 74 1.0× 40 350
Jessie Gu United States 9 147 1.1× 53 0.4× 64 0.6× 187 2.2× 192 2.7× 17 724
Michael Z. Liao United States 12 70 0.5× 66 0.5× 53 0.5× 180 2.1× 44 0.6× 24 384
Katsunori Tauchi Japan 11 127 0.9× 39 0.3× 30 0.3× 118 1.4× 65 0.9× 47 406

Countries citing papers authored by Amy A. Irving

Since Specialization
Citations

This map shows the geographic impact of Amy A. Irving's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy A. Irving with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy A. Irving more than expected).

Fields of papers citing papers by Amy A. Irving

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy A. Irving. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy A. Irving. The network helps show where Amy A. Irving may publish in the future.

Co-authorship network of co-authors of Amy A. Irving

This figure shows the co-authorship network connecting the top 25 collaborators of Amy A. Irving. A scholar is included among the top collaborators of Amy A. Irving based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy A. Irving. Amy A. Irving is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Irving, Amy A., et al.. (2022). Vitamin D receptor absence does not enhance intestinal tumorigenesis in ApcPirc/+rats. Biology Open. 11(7). 4 indexed citations
2.
Irving, Amy A., et al.. (2019). UV light suppression of EAE (a mouse model of multiple sclerosis) is independent of vitamin D and its receptor. Proceedings of the National Academy of Sciences. 116(45). 22552–22555. 18 indexed citations
3.
Irving, Amy A., Zhishi Wang, Linda Clipson, et al.. (2018). The conserved protective cyclic AMP-phosphodiesterase function PDE4B is expressed in the adenoma and adjacent normal colonic epithelium of mammals and silenced in colorectal cancer. PLoS Genetics. 14(9). e1007611–e1007611. 13 indexed citations
4.
Irving, Amy A., et al.. (2018). Vitamin D deficiency in the ApcPirc/+ rat does not exacerbate colonic tumorigenesis, while low dietary calcium might be protective. Disease Models & Mechanisms. 11(3). 6 indexed citations
5.
Irving, Amy A., et al.. (2017). Suppression of experimental autoimmune encephalomyelitis by ultraviolet light is not mediated by isomerization of urocanic acid. BMC Neuroscience. 18(1). 8–8. 10 indexed citations
6.
Irving, Amy A., et al.. (2014). The Concentrations of EGFR, LRG1, ITIH4, and F5 in Serum Correlate with the Number of Colonic Adenomas in ApcPirc /+ Rats. Cancer Prevention Research. 7(11). 1160–1169. 15 indexed citations
7.
Irving, Amy A., et al.. (2014). A simple, quantitative method using alginate gel to determine rat colonic tumor volume in vivo.. PubMed Central. 6 indexed citations
8.
Irving, Amy A., et al.. (2014). Cholecalciferol or 25-Hydroxycholecalciferol Neither Prevents Nor Treats Adenomas in a Rat Model of Familial Colon Cancer,. Journal of Nutrition. 145(2). 291–298. 14 indexed citations
9.
Irving, Amy A., Kazuto Yoshimi, Marcia L. Hart, et al.. (2014). The utility of Apc-mutant rats in modeling human colon cancer. Disease Models & Mechanisms. 7(11). 1215–25. 49 indexed citations
10.
Huttlin, Edward L., Xiaodi Chen, Amy A. Irving, et al.. (2013). Candidate Serum Biomarkers for Early Intestinal Cancer Using 15N Metabolic Labeling and Quantitative Proteomics in the ApcMin/+ Mouse. Journal of Proteome Research. 12(9). 4152–4166. 24 indexed citations
11.
Amos‐Landgraf, James, Amy A. Irving, Anthony M. Hunter, et al.. (2012). Monoallelic silencing and haploinsufficiency in early murine intestinal neoplasms. Proceedings of the National Academy of Sciences. 109(6). 2060–2065. 11 indexed citations
12.
Cohen, Eric P., Meena Bedi, Amy A. Irving, et al.. (2011). Mitigation of Late Renal and Pulmonary Injury After Hematopoietic Stem Cell Transplantation. International Journal of Radiation Oncology*Biology*Physics. 83(1). 292–296. 52 indexed citations
13.
Irving, Amy A., Richard B. Halberg, Dawn M. Albrecht, et al.. (2011). Supplementation by vitamin D compounds does not affect colonic tumor development in vitamin D sufficient murine models. Archives of Biochemistry and Biophysics. 515(1-2). 64–71. 21 indexed citations
14.
Sieber, Fritz, Eric P. Cohen, Paula E. North, et al.. (2009). High-Dose Selenium for the Mitigation of Radiation Injury: A Pilot Study in a Rat Model. Radiation Research. 171(3). 368–373. 35 indexed citations
15.
Cohen, Eric P., Brian L. Fish, Amy A. Irving, et al.. (2009). Radiation Nephropathy is not Mitigated by Antagonists of Oxidative Stress. Radiation Research. 172(2). 260–264. 21 indexed citations
16.
Lenarczyk, Marek, Eric P. Cohen, Brian L. Fish, et al.. (2009). Chronic Oxidative Stress as a Mechanism for Radiation Nephropathy. Radiation Research. 171(2). 164–172. 39 indexed citations
17.
Halberg, Richard B., et al.. (2008). Cyp1b1 Exerts Opposing Effects on Intestinal Tumorigenesis via Exogenous and Endogenous Substrates. Cancer Research. 68(18). 7394–7402. 20 indexed citations
18.
Cohen, Eric P., Amy A. Irving, William R. Drobyski, et al.. (2007). Captopril to Mitigate Chronic Renal Failure After Hematopoietic Stem Cell Transplantation: A Randomized Controlled Trial. International Journal of Radiation Oncology*Biology*Physics. 70(5). 1546–1551. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026